Mon 15 May 2023 the Epigenetics in human health and disease program relocates to BHRIBaker Heart and Diabetes Institute (BHRI)Central Clinical School, Monash University Professor El-Osta is an epigeneticist and his research is recognized at the highest international level.He has contributed more than 200 articles and publishes research that is highly influential in the field of transcription and chromatin biology. In recognition of his research into epigenetics, he was awarded AMGEN Australian Medical Researcher of the Year in 2006 by the ASMR Australian Society for Medical Research.The inclusion of his prominent research into the Faculty of 1000 Biology and Nature Milestones as well as most read articles in Circulation Research "honor roll" for 2011 exemplify an authoritative position, influence, and international reputation. While frequently invited to write editorials, his research is recognized in editorials and was awarded in the “2013 Anthology” of most significant science in Circulation Research.He was recently elected vice-president of the International Epigenetics Society and serve as guest editor and solicited to contribute authoritative reviews for prominent journals that in 2015/16 include Antioxidants & Redox Signaling, Cellular and Molecular Life Sciences, Molecular Aspects of Medicine and Circulation Research. As well as his promotion to Professor in 2013 and in recognition of excellence in supervision and mentoring, in 2015, he is an adjunct Professor in epigenetics at the Prince of Wales Hospital, Hong Kong as well as visiting lecturer with Kobenhavns Professionshojskole, University College Copenhagen (formerly known as Metropolitan University College and recently merged with University College Capital) in Denmark.His highly original contributions are influential and reflected by prestigious international invitations that include keynote and plenary lectures, which in 2016 include EAS (Austria), EASD (Munich) and IDF-WPR (Taipei). Since 2011, he has received >$6 Million dollars in external research funding, which has become more diversified to include not only NHMRC and Centre of Research Excellence funding but also competitive international sources such as the European Union and FP7 and JDRF.In 2009 he was awarded the prestigious Millennium Type 1 Diabetes Research Award by the Diabetes Australia Research Trust and received the inaugural Juvenile Diabetes Research Foundation & Macquarie Group Foundation in 2009 for diabetes research innovation, in recognition excellence and innovation in medical research.